Neoleukin Therapeutics (NASDAQ:NLTX) Hits New 52-Week High – What’s Next?
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report)’s share price reached a new 52-week high on Monday . The stock traded as high as $74.49 and last traded at $71.53, with a volume of 315873 shares changing hands. The stock had previously closed at $68.21. Neoleukin Therapeutics Price Performance The company has a market cap […]
More Stories
Financial Analysis: Tejon Ranch (NYSE:TRC) versus Safe and Green Development (NASDAQ:SGD)
Insider and Institutional Ownership 60.6% of Tejon Ranch shares are held by institutional investors. Comparatively, 2.6% of Safe and Green...
Exploring Different Types of Loans and How They Can Benefit Individuals and Businesses
For many, loans are essential financial tools that open the door to significant life goals, from purchasing a home to...
Security National Financial (NASDAQ:SNFCA) Rating Increased to Strong-Buy at StockNews.com
StockNews.com upgraded shares of Security National Financial (NASDAQ:SNFCA – Free Report) from a hold rating to a strong-buy rating in...
Aptose Biosciences (NASDAQ:APTO) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a research report sent to investors...
IAC (NASDAQ:IAC) & Eventbrite (NYSE:EB) Head to Head Analysis
Eventbrite (NYSE:EB – Get Free Report) and IAC (NASDAQ:IAC – Get Free Report) are both computer and technology companies, but...
Haiti: Child recruitment by armed groups surges 70 per cent
The number of children being recruited into armed groups across Haiti has increased by 70 per cent over the past...